Back
Freeport-McMoRan 10K Form
Buy
59
FCX
Freeport-McMoRan
Last Price:
45.02
Seasonality Move:
6.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | FCX/Freeport-McMoRan Quarterly |
2024-02-16 | 10K | FCX/Freeport-McMoRan Annual |
2023-11-03 | 10Q | FCX/Freeport-McMoRan Quarterly |
2023-08-03 | 10Q | FCX/Freeport-McMoRan Quarterly |
2023-05-04 | 10Q | FCX/Freeport-McMoRan Quarterly |
2023-02-15 | 10K | FCX/Freeport-McMoRan Annual |
Receive FCX News And Ratings
See the #1 stock for the next 7 days that we like better than FCX
FCX Financial Statistics
Sales & Book Value
Annual Sales: | $22.86B |
---|---|
Cash Flow: | $673M |
Price / Cash Flow: | 31.83 |
Annual Sales: | $12.21 |
Price / Book: | 3.81 |
Profitability
EPS (TTM): | 1.37000 |
---|---|
Net Income (TTM): | $2B |
Gross Margin: | $7.16B |
Return on Equity: | 7.17% |
Return on Assets: | 3.73% |
Freeport-McMoRan Earnings Forecast
Key Freeport-McMoRan Financial Ratios
- The Gross Profit Margin over the past 37 years for FCX is 31.33%.
- The Selling, General & Administrative Expenses for FCX have been equal to 2.10% of Gross Profit Margin.
- The Research & Development expenses have been 0.57% of Revenue.
- The Interest Expense is 27.87% of Operating Income.
- The Net Earning history of FCX is 8.09% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 20 years.
Freeport-McMoRan Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | FCX |
CUSIP: | 35671D |
Website: | fcx.com |
Debt
Debt-to-Equity Ratio: | 0.55 |
---|---|
Current Ratio: | 2.33 |
Quick Ratio: | 1.05 |
Price-to-Earnings
Trailing P/E Ratio: | 36.38 |
---|---|
Forward P/E Ratio: | 21.21 |
FCX Technical Analysis vs Fundamental Analysis
Buy
59
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy or a Sell?
-
Freeport-McMoRan stock is rated a Buy
The current Freeport-McMoRan [FCX] share price is $45.97. The Score for FCX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.